Background: p38α MAPK is activated by stress stimuli, which can regulate cell death.
Results: In response to H2O2, p38α MAPK increases SOD and catalase levels, impairs ROS accumulation, and leads to cell survival.
Conclusion: p38α MAPK signals survival under moderate oxidative stress through up-regulation of antioxidant defenses.
Significance: To know how p38α regulates ROS levels is important for cell homeostasis.
Keywords: Apoptosis, Cell Signaling, Oxidative Stress, p38 MAPK, Redox Signaling, ATF-2, p70S6K
Abstract
We reveal a novel pro-survival role for mammalian p38α in response to H2O2, which involves an up-regulation of antioxidant defenses. The presence of p38α increases basal and H2O2-induced expression of the antioxidant enzymes: superoxide-dismutase 1 (SOD-1), SOD-2, and catalase through different mechanisms, which protects from reactive oxygen species (ROS) accumulation and prevents cell death. p38α was found to regulate (i) H2O2-induced SOD-2 expression through a direct regulation of transcription mediated by activating transcription factor 2 (ATF-2) and (ii) H2O2-induced catalase expression through regulation of protein stability and mRNA expression and/or stabilization. As a consequence, SOD and catalase activities are higher in WT MEFs. We also found that this p38α-dependent antioxidant response allows WT cells to maintain an efficient activation of the mTOR/p70S6K pathway. Accordingly, the loss of p38α leads to ROS accumulation in response to H2O2, which causes cell death and inactivation of mTOR/p70S6K signaling. This can be rescued by either p38α re-expression or treatment with the antioxidants, N-acetyl cysteine, or exogenously added catalase. Therefore, our results reveal a novel homeostatic role for p38α in response to oxidative stress, where ROS removal is favored by antioxidant enzymes up-regulation, allowing cell survival and mTOR/p70S6K activation.
Introduction
The intracellular redox state is tightly regulated because it is essential for the control of cell fate. High levels of ROS5 can lead to molecular damage and cell death, whereas low ROS levels can be essential second messengers (1). Pro-oxidant and antioxidant systems are involved in this regulation, preventing an excessive accumulation of ROS.
Different members of the MAPK family, such as ERKs, JNKs, and p38, can be activated by ROS (1). This activation leads to a great variety of biological responses, including cell death or survival. Hence, although the stress MAP kinases can induce apoptosis in response to oxidative stress (2, 3), differences in the duration and magnitude of the oxidative stress might be directly proportional to the state of activation of these kinases, and this might determine cell death or survival.
p38α MAPK plays an important role in the coordination of cellular stress responses to signals such as ROS. In fact, it is well known that p38α MAPK plays an important role in mediating apoptosis (4) and/or senescence induced by different stimuli, including ROS (5, 6). For example, ROS generated by oncogenic H-Ras induces apoptosis through p38α activation, inhibiting tumor initiation (7). In contrast, low levels of oxidative stress can also induce cell cycle arrest (8) or cell survival (9, 10) through p38. Initially, stress signaling mechanisms are pro-survival systems because they tend to repair damage before committing cells to death or senescence. Interestingly, p38α can mediate survival upon activation with H2O2 (10), and p38α and β can have pro-survival roles (11–13) such as during quiescence of dormant tumor cells (14). However, the precise mechanisms by which p38 signaling achieves cell survival are poorly understood.
We have previously demonstrated that Akt activity is negatively regulated by p38α (15), and recent data from Nogueira et al. (16) showed that Akt activation sensitized cells to oxidative stress through down-regulation of ROS scavengers leading to the accumulation of intracellular ROS and cell death. Therefore, we hypothesized that p38α, through inhibition of Akt, might allow a proper expression of antioxidant genes and cell survival. Thus, we analyzed the precise function of p38α in the regulation of the cell fate using nontransformed WT and p38α−/− MEFs exposed to oxidative stress. Furthermore, we explored the mechanisms involved in the regulation of antioxidant responses, in the context of Akt/mTOR signaling, as well as other pathways linked to ROS level regulation.
EXPERIMENTAL PROCEDURES
Cell Lines, Culture Conditions, and Inhibitors
WT and p38α-deficient MEFs, immortalized either by passages or by LTAg (Large T Antigen) expression, were grown in DMEM supplemented with 10% FBS (Invitrogen) at 37 °C in a humidified atmosphere with 5% CO2. For signaling experiments, confluent cells were stimulated with 0.1–1 mm H2O2 for 20 min. For cell death analysis, growing cells were treated with 0.1–1 mm H2O2 for 6–24 h. The mTORC1 inhibitor, rapamycin was used at a concentration of 1–10 μm.
Treatment with Antioxidants, Actinomycin D, and MG-132
The cells were treated with the following antioxidants to decrease intracellular levels of ROS and/or to metabolize H2O2: 50 units/ml of catalase (Sigma; C-1345) and 2.5 mm N-acetyl cysteine (Sigma; A-9165). The antioxidants were added 1 h before H2O2 treatment. To inhibit transcription, the cells were treated with actinomycin D (Sigma; A9415) at 5 μg/ml. To block proteasome-dependent proteins degradation cells were treated with the proteasome inhibitor MG-132 at 1 μm.
Transfection Assays
To re-express p38α MAPK in p38α−/− MEFs or to express WT and constitutive active p70S6K, transient transfections were performed using Metafectene-Pro and the following constructs containing: (i) human p38α cDNA cloned into the EcoRI site of the pEFmlink expression vector (4); (ii) wtp70; and (iii) p70Δ29–46 ΔCT104 (deletion of amino acids 29–46 and C-terminal tail, 422–525) active mutant cloned in PMT2 vector containing HA tag (Addgene plasmid 1892) (17). The protocol supplied by the manufacturer was followed using 7 μl/1 μg of DNA/dish (20.000 cells). The cell assays were performed 48 h after transfection.
ATF-2 RNA Interference
Transfections of cells with siRNA targeting ATF-2 (Cell Signaling; 6433) or a control scrambled siRNA (Ambion) diluted in medium without serum at a final concentration of 50 nm were performed using siPORT NeoFX transfection reagent (Ambion) following the manufacturer's instructions. Trypsinized cells were resuspended and overlaid onto the transfection complexes. After 24 h under normal cell culture conditions, protein and RNA was isolated, or cell viability was quantified.
SOD-2 Luciferase Analysis
To assess SOD-2 promoter activity upon H2O2 treatment in WT and p38α−/− MEFs, the cells were cotransfected with a construct containing the SOD-2 promoter coupled to luciferase reporter (kindly provided by Daret St. Clair, Kentucky University) and a plasmid-encoding Renilla luciferase (Clontech) (100–500 ng). Then cells were treated with H2O2 0.5 mm for 4 and 8 h and lysed using the passive lysis buffer from Promega. Luciferase activity was detected with a luminometer (Molecular Devices Spectramax M5E) using a dual luciferase reporter kit from Promega following the manufacturer's instructions. Luciferase activity was normalized to Renilla luciferase activity.
Western Blot Analysis
Western blot analysis was carried out as previously described using total cell extracts (15). Proteins were separated by electrophoresis using Anderson gels (or SDS-PAGE gels) and transferred to nitrocellulose membranes that were probed with the following antibodies: Akt (Cell Signaling; 9272), catalase (Sigma; C-0979), p70S6K (Cell Signaling; 9202), p38α (Santa Cruz; sc-535), phospho-acetyl-CoA-carboxylase (Cell Signaling; 3661), phospho-Akt (Cell Signaling; 9271), phospho-AMPK (Cell Signaling; 2531), phospho-MKK3/6 (Cell Signaling; 9231), SOD-2 (Upstate Biotech; 06-984), TSC-1 (Cell Signaling; 4906), phospho-TSC-2 (Cell Signaling; 3615), phospho-p38 (Cell Signaling; 9211), phospho-p70S6K (Cell Signaling; 4376), anti-HA Clone 16 B12 (Covance; MMS-101P), phospho-ATF-2 (Cell Signaling; 9221), ATF-2 (Cell Signaling; 9226), and α-tubulin (Sigma; T-5168).
Catalase and SOD Activity Assays
Catalase activity was measured by quantification of peroxide decomposition in a 50 mm phosphate buffer at pH 7 containing 3 mm H2O2. This was monitored spectrophotometrically at 240 nm. SOD activity from cell extracts was quantified using a kit (BioVision, reference number K335-100), where WST-1 (2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfo-phenyl)-2H tetrazolium, monosodium salt) is the substrate. WST-1 produces a water-soluble formazan dye upon its reduction with superoxide anion, which can be monitored spectrophotometrically at 450 nm. The rate of the reduction is linearly related to the xanthine oxidase activity and inhibited by SOD, so the IC50 of SOD is determined as a measure of SOD activity.
RT-PCR and RT-Quantitative PCR Analysis
After the isolation of total RNA with RNeasy Mini kit (Qiagen; 74104), 1–3 μg of RNA was reverse transcribed with SuperScrip III RT kit (Qiagen; 18080) to generate cDNA. Then PCR analysis was performed using specific primers: for SOD-1: forward, 5′GATGAAGAGAGGCATGTTGG-3′, and reverse, 5′-CCAATGATGCAATGGTCTCC-3′ (n141–n160 and n554–n573, respectively; accession number 000082.5); and for SOD-2: forward, 5′TGGGGCTGGCTTGGCTTCAA-3′, and reverse, 5′GCGTGCTCCCACACGTCAAT-3′ (n646–n665 and n751–n770, respectively; accession number 000083.5). The amplified bands were normalized using internal control: GAPDH, forward, 5′-CATCAAGAAGGTGGTGAAGC-3′, and reverse, 5′-CATCGAAGGTGGAAGAGT TGG-3′ in the same PCR. The conditions for the PCR were: 94 °C for 45 s, 55 °C for 45 s, and 72 °C for 1 min for 30 cycles. Quantitative analysis of catalase mRNA levels was performed by real time PCR using SYBR Green (Roche Applied Science) and the following specific primers: forward, 5′-GTCACCGGCACATGAATGGCT-3′ (n738–n759), and reverse, 5′-TGATGCCCTGGTCGGTCTTGT-3′ (n817–n839) using GAPDH primers (referred above) to normalize.
Chromatin Immunoprecipitation Assay
ChIP assay was performed essentially as described previously (18). Briefly, the cells (3 × 106) were fixed in 1% formaldehyde solution (15 min) to cross-link DNA with associated proteins. The cross-linking reaction was finished by the addition of 125 mm glycine (5 min), and cells were washed and harvested in PBS containing protease and phosphatase inhibitors. The pelleted cells were lysed on ice in a buffer containing 1% SDS, 10 mm EDTA, 50 mm Tris-HCl, pH 8.1, and protease and phosphatase inhibitors. Then cells were sonicated 10 seconds × 6 (at level 4 and 40% of potency). DNA was fragmented in a range of 200–600 bp. Equal amounts of chromatin were diluted in ChIP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mm EDTA, 16.7 mm Tris-HCl, pH 8.1, 167 mm NaCl) and incubated overnight at 4 °C with a P-ATF-2 antibody or a rabbit IgG (negative control), followed by 1 h of incubation with salmon sperm DNA/protein A-agarose beads. 10% of the sample was kept as an input. Then samples were centrifuged, and protein A-agarose beads pellets were sequentially washed with a low salt buffer (0.1% SDS, 1% Triton X-100, 2 mm EDTA, 20 mm Tris-HCl, pH 8.1, 150 mm NaCl); a high salt buffer (0.1% SDS, 1% Triton X-100, 2 mm EDTA, 20 mm Tris-HCl, pH 8.1, 500 mm NaCl); a LiCl wash buffer (0.25 m LiCl, 1% Nonidet P-40, 1% deoxycholate, 1 mm EDTA, 10 mm Tris-HCl, pH 8.1); and TE (10 mm Tris-HCl, 1 mm EDTA, pH 8.0). Protein-DNA complexes were eluted in a buffer containing 1% SDS and 0.1 m NaHCO3. Then cross-linking was reversed by incubation in 200 mm NaCl for 4 h at 65 °C followed by incubation in 40 mm Tris-HCl, pH 6.5, 10 mm EDTA, and 20 μg of proteinase K for 1 h at 45 °C to eliminate proteins. DNA was then extracted with phenol/chloroform, precipitated, and analyzed by PCR using primers for AP-1 site (positions 844–853) from mouse SOD-2 promoter: forward, 5′-GCAAGCAGCAGAACTCGCAGC-3′, and reverse, 5′-AGCACTCAGGAGGCAGAGGCA-3′. Inputs were also analyzed by PCR.
Analysis of Cell Viability and Apoptosis
Cell viability was assayed through staining of adhered (viable) cells with crystal violet. The cells were washed with PBS, incubated with a crystal violet solution (0.2%, w/v) for 20 min, washed, and dried. Stained cells were lysed in 1% SDS, and absorbance at 560 nm was measured.
Apoptotic cells were quantified by flow cytometric analysis of the cell cycle. The cells were trypsinized, washed with PBS, and fixed with cold ethanol (70% v/v). Then they were washed, resuspended in PBS, and incubated with RNase (25 μg/106 cells) for 30 min at 37 °C. After the addition of 0.05% propidium iodide, the cells were analyzed in the cytometer. The percentage of cells in sub-G1 was determined and considered as apoptotic.
To analyze condensed and fragmented nuclei, characteristic of apoptosis, they were stained with propidium iodide (5 μg/ml in PBS, 0.1% Triton X-100, 0.1 m EDTA supplemented with 5 μg/ml RNase) (19) and visualized by fluorescent microscopy. Apoptotic indices were calculated after counting 500–1,000 cells/treatment in an inverted fluorescence microscope (Eclipse TE300; Nikon).
Measurement of Intracellular ROS
The cells were incubated with 5 μm 2′,7′-dichlorfluorescein-diacetate (DCFH) (Sigma; 35845) in PBS for 30–60 min and then treated with H2O2 (0.1–1 mm) for 15 min. Finally, the cells were washed with PBS and analyzed in an inverted fluorescence microscope (Eclipse TE300; Nikon).
Statistical Analysis
The data are represented as the means ± S.E. The comparisons were made between two experimental groups. An unpaired Student's t test was used, and alternatively, an analysis of variance test was carried out for comparisons of more than two experimental groups.
RESULTS
Loss of p38α Sensitizes Cells to H2O2-induced Cell Death
We first tested viability of WT and p38α Knock-out MEFs in response to a level of oxidative stress able to generate damage but not massive toxicity. As shown in Fig. 1A, WT MEFs exhibited a higher resistance to H2O2 (0.1–0.5 mm) than p38α-deficient MEFs. This suggests that p38α allows cells to survive under mild levels of oxidative stress. This was confirmed by p38α reconstitution in p38α−/− cells, which increased cell viability in response to H2O2 up to the levels observed in WT cells (Fig. 1B). The morphological analysis of nuclei showed a significantly higher number of condensed and/or fragmented nuclei in p38α-deficient MEFs than in WT cells upon H2O2 treatment (Fig. 1C), which suggests that cells would be dying by apoptosis. These data demonstrate that p38α protects from low levels of H2O2-induced cell death.
FIGURE 1.
p38α protects from H2O2-induced cell death. MEFs (WT and p38α−/−) maintained in the presence of serum were treated with H2O2 when indicated. A, p38α expression increases cell viability in cells treated with H2O2 (0.1 or 0.5 mm) for 24 h. B, p38α reconstitution in p38α−/− cells (Rec) rescues cells from cell death upon treatment with H2O2 (1 mm) for 6 h. The data correspond to cell viability expressed as percentages, and p38α expression was determined by Western blot and normalized with tubulin. C, loss of p38α increases the number of apoptotic nuclei in cells treated with H2O2 (0.5 mm) for 3 h. *, p < 0.05 and ***, p < 0.001, p38α−/− versus WT MEFs upon treatment with H2O2.
Loss of p38α MAPK Impairs mTOR/p70S6K Activation in Response to H2O2 through Akt-independent Mechanisms
Akt is involved in the activation of mTORC1 through the phosphorylation and inactivation of TSC-2, which inhibits mTOR through inhibition of Rheb (20, 21). We have previously shown that Akt activity is negatively regulated by p38α (15), so that Akt is hyperactivated in p38α−/− cells, leading to increased survival in response to serum deprivation (15). However, whether this has any effect on ROS sensitivity remains unknown. Recently, Nogueira et al. (16) showed that Akt activation sensitized cells to oxidative stress through down-regulation of ROS scavengers, which increased intracellular ROS. This led us to hypothesize that p38α, through inhibition of Akt, might allow a proper expression of antioxidant genes. Thus, we next tested the activation of the Akt/mTOR/p70S6K pathway in response to H2O2 in WT and p38α-deficient MEFs. As shown in Fig. 2A, Akt phosphorylation in response to H2O2 (0.1–1 mm) was higher (particularly, at 0.5 mm) in p38α−/− than in WT MEFs. Surprisingly, this activation was uncoupled from mTOR-mediated p70S6K phosphorylation in Thr-389, because phosphorylation at this site was markedly reduced in p38α-deficient cells. Under these conditions, p38α was activated by H2O2 in WT cells, whereas in p38α−/− MEFs another p38 isoform with a higher mobility was slightly activated (Fig. 2A). Therefore, these data suggest that in the absence of p38α, mTOR/p70S6K pathway activation becomes uncoupled from that of Akt and is impaired in response to H2O2 treatment. This was confirmed by p38α reconstitution in p38α−/− cells, which rescued the levels of p70S6K activation (see Thr(P)-389-p70S6K levels; Fig. 2B), reaching a level comparable with WT cells treated with H2O2.
FIGURE 2.
p38α MAPK positively regulates p70S6K through an Akt independent mechanism. MEFs (WT and p38α−/−) maintained in the presence of serum were treated with H2O2 (0.1–1 mm in A, 1 mm in B and C) for 20 min when indicated. Western blot analysis of the levels of Thr(P)-389-p70S6K (P-Thr389-p70S6K), Ser(P)-939-TSC-2 (P-Ser939-TSC-2), Ser(P)-473-Akt (P-Ser473-Akt), Thr(P)-172-AMPK (P-Thr172-AMPK), Ser(P)-79-acetyl-CoA-carboxylase (P-Ser79-ACC), Thr/Tyr(P)-180/182-p38 MAPK (P-Thr/Tyr-180/182-p38 MAPK) (P-p38) Ser (P)-189/207-MKK3/MKK6 (P-Ser-189/207-MKK3/MKK6) (P-MKK3/6), as well as total levels of p70S6K, Akt, TSC-1, and p38α normalized with tubulin are shown. A and B, effect of p38α expression on the activation of Akt and p70S6K in response to H2O2. p38α-deficient cells show a decrease activation of p70S6K as compared with WT or p38α−/− with reconstitution of p38α (Rec). C, analysis of the activation of the p70S6K pathway by p38α showing p70S6K phosphorylation by mTOR and the activation of different upstream regulators (positive and negative). P-p70/tubulin represents the relative value resulting from the densitometric analysis of Thr(P)-389-p70S6K versus tubulin levels multiplied by 10.
To gain further insight into the mechanisms involved in the regulation of mTOR/p70S6K pathway by p38α, we analyzed whether the regulators of mTORC1 were differentially modulated in the absence of p38α. As shown in Fig. 2C, the high level of Akt phosphorylation in p38α-deficient cells was correlated with Akt-mediated TSC-2 phosphorylation in Ser-939 (an inhibitory site) in response to H2O2, whereas TSC-1 and TSC-2 levels remained unchanged in all cases. Nevertheless, this did not result in a high activation of mTOR/p70S6K pathway. Hence, we measured activation of AMPK, an inhibitor of mTORC1 pathway. However, phosphorylation of AMPK (in Thr-172) and its substrate, acetyl-CoA-carboxylase in response to H2O2 was enhanced in WT MEFs (Fig. 2C). As a consequence, these changes in AMPK activity in WT and p38α-deficient cells did not explain the higher activation of mTOR/p706SK in WT cells exposed to oxidative stress. Therefore, neither TSC-1/2 nor AMPK appear to mediate the inhibition of mTOR signaling observed in p38α−/− cells, which indicates that other mechanisms might be involved. However, it is clear that Akt and AMPK signaling is uncoupled from mTOR/p70S6K activation under these conditions.
We considered the possibility that the higher mTOR/p70S6K activation in cells expressing p38α could be responsible for the increased survival in response to H2O2. Thus, we inhibited this pathway with rapamycin to evaluate it. As shown in Fig. 3A, treatment with rapamycin completely abolished p70S6K phosphorylation by mTOR in response to H2O2. However, rapamycin did not sensitize WT cells to ROS-induced cell death (Fig. 3B). Thus, the higher activation of mTOR/p70S6K appears not to be responsible for the p38α-mediated increased survival. Nevertheless, rapamycin was able to decrease cell size in WT cells but not in those deficient in p38α (data not shown), suggesting a potential function for the p38α-mTOR pathway promoting and/or maintaining cell size and homeostasis under oxidative stress conditions. This is in agreement with recent published results (22). Moreover, transfection of either an active p70S6K (p70Δ29–46 ΔCT104 mutant) or a WT p70S6K construct did not increase the cell viability of p38α-deficient MEFs treated with H2O2 (Fig. 3C). In contrast, basal viability was slightly reduced upon expression of these p70S6K constructs.
FIGURE 3.
mTORC1/p70S6K does not mediate p38α-dependent survival in response to H2O2. MEFs (WT and p38α−/−) maintained in the presence of serum were treated with H2O2 (0.1, 0.5, or 1 mm) when indicated. A, effect of mTORC1 inhibition by rapamycin (Rapa) on H2O2-induced activation p70S6K and Akt. Western blot analysis of the levels of Thr(P)-389-p70S6K (P-Thr389-p70S6K) and Ser(P)-473-Akt (P-Ser473-Akt) normalized with tubulin upon treatment with H2O2 for 20 min. B, effect of rapamycin on H2O2-induced apoptosis (left panel) and cell viability (right panel) after 24 h. The results show the percentage of hypodiploid cells (apoptotic cells) analyzed by flow cytometry and the percentage of viable cells determined by crystal violet staining. *, p < 0.05, p38α−/− versus WT MEFs treated with 0.1 mm H2O2. No significant differences were found in the presence of rapamycin. C, effect of the expression of transfected WT p70S6K and p70Δ29–46ΔCT104 active mutant on cell viability. *, p < 0.05, p38α−/− versus WT MEFs treated with H2O2. No significant differences were found upon expression of WT p70S6K and p70Δ29–46ΔCT104. Western blot analysis shows HA expression in cells transfected with WT p70S6K and p70Δ29–46ΔCT104 active mutant. Arrows indicate the migration of 80- and 50-kDa molecular weight markers.
On the other hand, Akt inhibition with the specific chemical inhibitor, A443354 (23) had no effect on H2O2-induced cell death, either in WT or p38α−/− MEFs (supplemental Fig. S1), which suggests that the Akt pathway does not play a major role in p38α-mediated survival. We also tested other pathways that could be potentially involved in cell death, such as JNKs. We found a higher JNK activation in p38α−/− MEFs in response to H2O2 and under basal conditions (supplemental Fig. S2). However, JNK inhibition with SP600125 did not decrease cell death, which indicates that JNK is not responsible for the enhanced cell death observed in p38α-deficient cells.
Activation of p38α Prevents the Accumulation of ROS upon H2O2 Treatment via Induction of Antioxidant Enzymes
We next explored alternative mechanisms by which p38α might protect cells from ROS damage, allowing cell survival. Although p38α MAPK is known to mediate cell death in response to oxidative stress (5–7), p38 has been shown to mediate the expression of antioxidant enzymes (24, 25). This led us to hypothesize that p38α through the regulation of the antioxidant response might maintain low ROS intracellular levels, leading to cell survival.
As shown in Fig. 4, the percentage of cells with detectable levels of ROS (positive for DCFH) was slightly higher in untreated p38α-deficient cells and was highly increased upon treatment with H2O2 in a dose-dependent manner. This suggests that upon treatment with H2O2, p38α−/− cells are unable to scavenge ROS, leading to a high and progressive accumulation of ROS (Fig. 4B).
FIGURE 4.
ROS accumulation upon H2O2 treatment is higher in cells lacking p38α. MEFs (WT and p38α−/−) were incubated with DCFH and treated with H2O2 (1 mm for A, and 0.1 and 1 mm for B) for 15 min. A, analysis of DCFH-positive cells using an inverted fluorescence microscope. B, percentage of DCFH-positive cells. **, p < 0.01, p38α−/− versus WT MEFs treated with the same dose of H2O2.
This high ROS accumulation in p38α-deficient cells could be a consequence of a deficiency in the activation of antioxidant mechanisms. Thus, we analyzed the expression of relevant antioxidant enzymes such as SOD or catalase. As shown in Fig. 5A, p38α−/− cells expressed lower protein levels of SOD-2 and catalase than WT cells under basal conditions. Moreover, upon treatment with H2O2, these cells were either unable to efficiently induce the expression of these enzymes, as observed for SOD-2, or had a delay and a reduced induction, as happens for catalase. These results suggest that impaired or delayed induction of antioxidant enzymes in p38α−/− MEFs could be responsible for its higher sensitivity to H2O2-induced cell death. This was supported by the fact that p38α reintroduction in p38α-deficient cells led to an increase in catalase protein levels after 2 h of treatment with H2O2 (Fig. 5B). In addition, basal and H2O2-induced catalase and SOD activities were significantly higher in WT than in p38α−/− MEFs (Fig. 5, C and D, respectively). Therefore, all of these data indicate that the presence of p38α highly increases the antioxidant activity of cells.
FIGURE 5.
Loss of p38α reduces the expression and activity of antioxidant enzymes. MEFs (WT and p38α−/−) maintained in the presence of serum were treated with H2O2 (0.5 mm) for the indicated time periods. A, catalase and SOD-2 protein levels determined by Western blot analysis and normalized with tubulin. B, rescue of catalase protein expression by p38α reconstitution in p38α−/− cells (Rec) treated with H2O2 for 2 h. Western blot analysis of catalase and p38α normalized with tubulin. A and B, catalase/tubulin and SOD-2/tubulin represents the relative value resulting from the densitometric analysis of catalase or SOD-2, respectively, versus tubulin levels multiplied by 10. C and D, catalase and SOD activities, respectively, are shown as a fold increase of that of WT untreated cells (9.35 milliunits/mg protein for catalase and 7.32 milliunits/mg protein for SOD). *, p < 0.05; **, p < 0.01; ***, p < 0.001. E, RT-PCR analysis of the expression of SOD-1 and SOD-2 mRNAs. F, SOD-2 reporter activity quantification using luciferase as reported. The results are expressed using arbitrary units. *, p < 0.05; ***, p < 0.001.
To get further insight into the role of p38α as a regulator of antioxidant enzyme expression, we measured SOD-1 and SOD-2 mRNAs levels by RT-PCR. The levels were significantly lower in p38α−/− cells under basal conditions, and H2O2 only induced an increase in SOD-1 mRNA after 20–60 min, whereas SOD-2 mRNA remained unchanged (Fig. 5E).
To better understand the regulation of SOD-2 expression by p38α in response to H2O2, we analyzed SOD-2 promoter activity using luciferase as a reporter. As shown in Fig. 5F, H2O2 treatment induced a significant increase in SOD-2 reporter activity in WT cells after 8 h, but not in p38α−/− MEFs. This lack of activation of SOD-2 promoter in the absence of p38α could be a consequence of the lower activation of the transcription factor ATF-2 (Fig. 6A). To address this issue, ATF-2 knockdown experiments were performed using an ATF-2 siRNA (which markedly reduced ATF-2 protein levels, Fig. 6B), and results showed a high decrease in SOD-2 mRNA levels in WT cells, either untreated or treated with H2O2 (Fig. 6B). Moreover, ChIP assays revealed a significant binding of P-ATF-2 to SOD-2 promoter in WT MEFs treated with H2O2, whereas in p38α−/− cells, there was no detectable binding (Fig. 6C). In addition, ATF-2 activation was required for p38α-mediated cell survival in the presence of H2O2, so its knockdown induced death of WT cells (Fig. 6D). Therefore, these results indicate that p38α through ATF-2 regulation induces SOD-2 expression and resistance to H2O2 treatment.
FIGURE 6.
ATF-2 is an important mediator of p38α in the induction of SOD-2 expression and cell viability upon H2O2 treatment. MEFs (WT and p38α−/−) maintained in the presence of serum were treated with H2O2 (0.1 and 0.5 mm in A or 0.5 mm in B–D) for different time periods, as indicated. A, Western blot analysis of the levels of P-ATF-2 normalized with β-actin. B, effect of ATF-2 siRNA on SOD-2 mRNA levels. Top panel, Western blot analysis of ATF-2 levels normalized with GAPDH; lower panel, histograms showing SOD-2 mRNA levels. *, p < 0.05; ***, p < 0.001. C, ChIP analysis of P-ATF-2 binding to SOD-2 promoter. PCR analysis of DNA immunoprecipitated by a P-ATF-2 antibody and of input DNA. D, effect of ATF-2 siRNA decreasing cell viability of WT MEFs treated with H2O2 for 24 h. **, p < 0.01.
We next explored the mechanisms involved in the regulation of catalase expression. Catalase mRNA levels were increased by H2O2 progressively at 2 and 4 h in both WT and p38α-deficient cells, but to a higher extend in WT cells at 4 h (Fig. 7A). However, after 8 h of treatment, catalase mRNA highly decreased to the level of control in p38α−/− cells, whereas in WT cells, these levels remained above control values. Inhibition of transcription by actinomycin D abolished the increase in catalase mRNA levels observed at 2 and 8 h, regardless of the presence of p38α. However, at 4 h it was just a partial decrease in catalase mRNA upon actinomycin D treatment, specially, in WT cells. This would suggest that increases in the catalase mRNA level are only partially dependent on transcription, and p38α might stabilize catalase mRNA at 4–8 h of treatment. In addition, the fact that the proteasome inhibitor MG-132 increased catalase protein levels only in p38α-deficient cells (Fig. 7B) strongly suggests that catalase protein would be also stabilized by p38α. Hence, based on these results, p38α might be a positive regulator of catalase through protein stabilization and mRNA expression and/or stabilization.
FIGURE 7.
The presence of p38α stabilizes catalase protein. MEFs (WT and p38α−/−) maintained in the presence of serum were treated with H2O2 (0.5 mm) in the presence or absence of actinomycin D (ActD) or MG-132 for the indicated time periods. A, analysis of catalase mRNA levels by RT-quantitative PCR in the presence or absence of actinomycin D. Catalase mRNA expression was normalized using GAPDH (catalase Ct − GAPDH Ct = ΔCt) and then referred to WT control values to calculate the RQ value (2−ΔΔCt). The histograms show the mean values ± S.E. *, p < 0.05; +, p < 0.05; **, p < 0.01; n = 4. B, effect of the proteasome inhibitor MG-132 on catalase protein expression. Western blot analysis of catalase normalized with tubulin. Catalase/tubulin represents the relative value resulting from the densitometric analysis of catalase versus tubulin levels multiplied by 10.
Treatment with Either the Antioxidant N-Acetyl Cysteine or Catalase Protects from ROS-induced Cell Death: Effect on mTOR/p70S6K Pathway
Our data indicate that p38α activation in MEFs can protect from H2O2-induced cell death through a mechanism that reduces ROS accumulation via induction of antioxidant enzymes. Thus, we next studied the effect of the antioxidant N-acetyl cysteine (NAC) on H2O2-induced cell death.
As shown in Fig. 8A, NAC significantly decreased the number of apoptotic nuclei induced by H2O2 in p38α−/− cells. This correlates with a decrease in Ser(P)-18-p53 levels (supplemental Fig. S3), so p53 could be an important mediator of this process of cell death. Moreover, NAC not only protected from cell death but also induced an increase in Thr(P)-389-p70S6K levels, which was particularly strong in p38α-deficient cells, reaching a similar level to that found in WT cells (Fig. 8B). In contrast, Akt and p38α phosphorylation decreased in NAC-treated cells. All of these results suggest that H2O2-induced cell death would be a consequence of the damage induced by ROS accumulation, which is higher in p38α−/−MEFs. Hence, because catalase levels were lower in these cells, we added exogenous catalase to mimic WT cells situation. As shown in Fig. 8A, catalase highly decreased the number of apoptotic nuclei in p38α-deficient MEFs treated with H2O2. In addition, a parallel increase in P-Thr389-p70S6K levels was observed (Fig. 8C). In contrast, pretreatment with the cell-permeable SOD mimetic, Mn-TBAP, which is a superoxide scavenger, neither protected p38α−/− MEFs from H2O2-induced cell death nor protected from mTOR/p70S6K inactivation (supplemental Fig. S4). Therefore, only the selective H2O2 scavenger, catalase, which is down-regulated in p38α-deficient cells, allows p70S6K activation in the presence of H2O2. Moreover, in agreement with the idea that a high accumulation of ROS impairs p70S6K activation, we observed that treatment of WT MEFs with a very high dose of H2O2 (5 mm) impaired p70S6K activation (supplemental Fig. S5), which indicates that a very high accumulation of ROS either prevents activation or inactivates the mTOR/p70S6K pathway.
FIGURE 8.
Treatment with the antioxidant, N-acetyl cysteine, or catalase protects from ROS-induced apoptosis and allows activation of p70S6K by mTOR. MEFs (WT and p38α−/−) maintained in the presence of serum were treated with H2O2 (1 mm) for 20 min (B) or 3 h (A). When indicated, the cells were pretreated for 1 h with NAC (2.5 mm) or catalase. A, effect of NAC and exogenous catalase on H2O2-induced apoptosis. The results show the percentage of apoptotic nuclei. ***, p < 0.001, p38α−/− versus WT MEFs upon treatment with H2O2; and ++, p < 0.01, as compared with p38α−/− MEFs treated with H2O2 plus NAC or catalase. B, effect of NAC on H2O2-induced p70S6K activation. C, effect of catalase on H2O2-induced p70S6K activation. B and C, Western blot analysis of the levels of Thr(P)-389-p70S6K (P-Thr 389-p70S6K) and Ser(P)-473-Akt (P-Ser 473-Akt) normalized with tubulin. P-p70/tubulin represents the relative value resulting from the densitometric analysis of Thr(P)-389-p70S6K versus tubulin levels multiplied by 10.
DISCUSSION
p38α plays an important role as a mediator of apoptosis in response to different stress stimuli (4, 15, 26), including oxidative stress (5, 7). For example, p38α functions as a tumor suppressor in the transformation induced by oncogenic H-Ras (7), because of its ability to induce apoptosis upon generation of ROS. However, we have recently found a survival effect of p38α in response to H2O2 (10), which agrees with some data from other groups (8, 9, 27). Therefore, we have further evaluated the mechanisms by which p38α might protect cells from oxidative stress.
Here, we reveal a pro-survival function of p38α, which is dependent on the regulation of the antioxidant response. In addition, we found that although this response is associated with reduced Akt activity and enhanced mTOR/p70S6K signaling, these cascades are not immediately responsible for the p38α-mediated survival effect, but instead their modulation is a consequence of the ROS content in the cells. In contrast, the enhanced mTOR/p70S6K signaling caused by p38 activation appears to favor cell size maintenance during stress, a function recently identified in Drosophila melanogaster cells (22). Hence, the loss of p38α induces ROS accumulation, which leads to cell death and inactivation of the mTOR/p70S6K pathway. Although we did not measure this process, autophagic cell death could contribute to the loss of cells observed in p38α-deficient cells treated with H2O2.
In agreement with the proposed role for p38α as a positive regulator of antioxidant enzymes expression, it was previously reported that p38 MAPK up-regulated catalase (24) and heme oxygenase-1 (25) mRNAs in response to H2O2. We have now characterized the precise role of p38α in the regulation of the expression and activity of different antioxidant enzymes, as well as the mechanisms involved. Our data reveal a novel function for p38α controlling (i) H2O2-induced SOD-2 expression through direct regulation of transcription via ATF-2 activation and (ii) basal and H2O2-induced catalase expression through regulation of mRNA expression and/or stability and protein stability (Fig. 9).
FIGURE 9.
The up-regulation of antioxidant genes by p38α MAPK promotes cell survival and allows p70S6K activation. Model showing the effect of p38α MAPK increasing the levels of the antioxidant enzymes SOD and catalase in response to H2O2 through different mechanisms, which leads to the removal of ROS. As a consequence, ROS levels decrease, which allows cell survival and mTOR/p70S6K activation.
It is worth highlighting that we describe for the first time a p38α-ATF-2-dependent transcriptional regulation of SOD-2 in response to H2O2. Previously, it had been shown that low levels of H2O2 induced ATF-2 expression (8) or activation through p38α MAPK (29), leading to growth arrest. A role for JNKs-ATF-2 and p38 MAPK in the regulation of heme oxygenase-1 in response to oxidative stress was also demonstrated (25). However, we now show that the p38α MAPK-ATF-2 cascade also mediates SOD-2 up-regulation and cell survival in response to low levels of oxidative stress.
In contrast to our results demonstrating that mTOR/p70S6K cascade is not responsible for the p38α-mediated survival effect in response to H2O2, there are a number of data in the literature proposing that p38 MAPK activation and/or mTOR inhibition are required for H2O2-induced cell death in other cell types (1, 5, 30–32). For example, in keratinocytes activation of p38 by AMPK contributes to H2O2-induced apoptosis, as well as to mTOR activity down-regulation (30). In PC12 cells, AMPK-mediated mTOR inhibition was shown to be partially responsible for the apoptotic cell death induced by H2O2 (32). Our findings are not incompatible with these results. They simply highlight the complexity of the mechanisms and that the function of these pathways may depend on the cell type, H2O2 dose, and duration of the stress signal.
Based on our results, it is unclear that Akt has any potential role in the response to H2O2 mediated by p38α in MEFs. The expression of SOD and catalase is higher in WT than in p38α−/− cells under basal conditions, when Akt activation is quite similar in both cell lines, and the Akt inhibitor does not affect survival. Hence, these findings do not support the involvement of Akt antagonizing the antioxidant response in these cells, as found in other systems (16).
Regarding the regulation of mTOR/p70S6K by H2O2, there are also conflicting data in the literature. Some data indicate that mTOR can be inhibited by H2O2 treatment through different mechanisms such as up-regulation of REDD1 (regulated in development and DNA damage response 1) (33) or inhibition of PDK1 and Akt, accompanied by AMPK activation (32). In addition, AMPK through p38-dependent and -independent mechanisms can decrease mTOR activation by H2O2 (30), mediating cell death (30, 32). In contrast, our results indicate that p38α do not act as a negative regulator of mTOR/p70S6K as previously suggested (26). This would be in agreement with previous data demonstrating a pro-survival role of p38α and a p38α-dependent activation of mTOR/p70S6K signaling in response to different types of stresses (22, 28). Hence, in agreement with the results of Cully et al. (22), we also found that in cells treated with H2O2 at a low dose, mTORC1 activation is dependent on p38α. We additionally found that p38α regulates mTORC1/p70S6K in an indirect way, which is dependent on ROS accumulation. Therefore, in cells lacking p38α, a high accumulation of ROS is produced, which impairs activation of this pathway. However, in the presence of either catalase or N-acetyl cysteine, which prevents a high ROS accumulation, mTOR/p70S6K can be activated in p38α-deficient cells treated with H2O2.
However, the mechanisms controlling mTOR by p38 can be different depending on the context. Hence, in quiescent tumor cells, activation of the transcription factor ATF6 via p38α up-regulates Rheb, which in turn activates mTOR and survival through an Akt-independent mechanism (28).
We conclude that p38α has a pro-survival function because of its ability to up-regulate antioxidant genes expression, preventing from a high accumulation of ROS upon exposure to low or moderate doses of H2O2 (Fig. 9). In this way, cell damage can be overcome, allowing cell survival and mTOR/p70S6K pathway activation. In contrast, in the absence of p38α the antioxidant defense is not properly activated, leading to ROS accumulation and high cell damage. As a consequence, the mTOR/p70S6K pathway is inactivated, which might avoid protein synthesis and cell growth of damaged cells. In agreement with other studies (21, 33), we also found that mTOR/p70S6K activation is dependent on p38α activation in an oxidative microenvironment. We believe this could be critical for other cellular responses such as autophagy that can also control cell size and to maintain cellular homeostasis and function.
Supplementary Material
Acknowledgments
We thank Dr. Giranda (Abbot Laboratories) for providing the Akt inhibitor, A-443654, Dr. D. K. St. Clair (Graduate Center for Toxicology, University of Kentucky, Lexington, KY) for the SOD2 luciferase promoter plasmid, and Dr. J. Avruch for the p70S6K constructs. We also thank Rebeca Rodríguez for valuable technical help with RT-PCRs, Western blots, and cell culture; Dr. C. Roncero for helpful discussions on RT-qPCR assay design; Dr. L. Goya for help with catalase assays; and Drs. M. Vallejo, M. Mirasierra, and S. Ropero for their advice about ChIP assays.
This work was supported, in whole or in part, by National Institutes of Health Grants CA109182 and ES017146 (to J. A. A.-G.). This work was also supported by Grants FIS-PI070071 and SAF-2010-20198-C02-01 from Ministry of Science and Innovation of Spain and Grant 920384 from Comunidad de Madrid/Universidad Complutense de Madrid (to A. P.), grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program, and a grant from New York Stem Cell Science (to J. A. A.-G.).

This article contains supplemental Figs. S1–S5.
- ROS
- reactive oxygen species
- SOD
- superoxide dismutase
- ATF
- activating transcription factor
- MEF
- mouse embryonic fibroblast
- DCFH
- 2′,7′-dichlorfluorescein-diacetate
- NAC
- N-acetyl cysteine
- mTOR
- mammalian target of rapamycin.
REFERENCES
- 1. Matsuzawa A., Ichijo H. (2008) Redox control of cell fate by MAP kinase. Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim. Biophys. Acta 1780, 1325–1336 [DOI] [PubMed] [Google Scholar]
- 2. Kyriakis J. M., Avruch J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807–869 [DOI] [PubMed] [Google Scholar]
- 3. Dong C., Davis R. J., Flavell R. A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55–72 [DOI] [PubMed] [Google Scholar]
- 4. Porras A., Zuluaga S., Black E., Valladares A., Alvarez A. M., Ambrosino C., Benito M., Nebreda A. R. (2004) p38α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell 15, 922–933 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., Minowa O., Miyazono K., Noda T., Ichijo H. (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2, 222–228 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Wada T., Penninger J. M. (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23, 2838–2849 [DOI] [PubMed] [Google Scholar]
- 7. Dolado I., Swat A., Ajenjo N., De Vita G., Cuadrado A., Nebreda A. R. (2007) p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11, 191–205 [DOI] [PubMed] [Google Scholar]
- 8. Kurata S. (2000) Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J. Biol. Chem. 275, 23413–23416 [DOI] [PubMed] [Google Scholar]
- 9. Zhang X., Shan P., Alam J., Fu X. Y., Lee P. J. (2005) Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J. Biol. Chem. 280, 8714–8721 [DOI] [PubMed] [Google Scholar]
- 10. Gutiérrez-Uzquiza A., Arechederra M., Molina I., Baños R., Maia V., Benito M., Guerrero C., Porras A. (2010) C3G down-regulates p38 MAPK activity in response to stress by Rap-1 independent mechanisms. Involvement in cell death. Cell. Signal. 22, 533–542 [DOI] [PubMed] [Google Scholar]
- 11. Nebreda A. R., Porras A. (2000) p38 MAP kinases. Beyond the stress response. Trends Biochem. Sci. 25, 257–260 [DOI] [PubMed] [Google Scholar]
- 12. Wagner E. F., Nebreda A. R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer. 9, 537–549 [DOI] [PubMed] [Google Scholar]
- 13. Cuenda A., Rousseau S. (2007) p38 MAP kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773, 1358–1375 [DOI] [PubMed] [Google Scholar]
- 14. Aguirre-Ghiso J. A. (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834–846 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Zuluaga S., Alvarez-Barrientos A., Gutiérrez-Uzquiza A., Benito M., Nebreda A. R., Porras A. (2007) Negative regulation of Akt activity by p38α MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1. Cell. Signal. 19, 62–74 [DOI] [PubMed] [Google Scholar]
- 16. Nogueira V., Park Y., Chen C. C., Xu P. Z., Chen M. L., Tonic I., Unterman T., Hay N. (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14, 458–470 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Weng Q. P., Andrabi K., Kozlowski M. T., Grove J. R., Avruch J. (1995) Multiple independent inputs are required for activation of the p70 S6 kinase. Mol. Cell. Biol. 15, 2333–2340 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Ferreiro I., Barragan M., Gubern A., Ballestar E., Joaquin M., Posas F. (2010) The p38 SAPK is recruited to chromatin via its interaction with transcription factors. J. Biol. Chem. 285, 31819–31828 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. del Castillo G., Factor V. M., Fernández M., Alvarez-Barrientos A., Fabregat I., Thorgeirsson S. S., Sánchez A. (2008) Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro. Am. J. Pathol. 172, 1238–1247 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Dann S. G., Selvaraj A., Thomas G. (2007) mTOR Complex1-S6K1 signaling. At the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 13, 252–259 [DOI] [PubMed] [Google Scholar]
- 21. Ma X. M., Blenis J. (2009) Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307–318 [DOI] [PubMed] [Google Scholar]
- 22. Cully M., Genevet A., Warne P., Treins C., Liu T., Bastien J., Baum B., Tapon N., Leevers S. J., Downward J. (2010) A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1. Mol. Cell. Biol. 30, 481–495 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Han E. K., Leverson J. D., McGonigal T., Shah O. J., Woods K. W., Hunter T., Giranda V. L., Luo Y. (2007) Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Oncogene 26, 5655–5661 [DOI] [PubMed] [Google Scholar]
- 24. Sen P., Chakraborty P. K., Raha S. (2005) p38 mitogen-activated protein kinase (p38MAPK) upregulates catalase levels in response to low dose H2O2 treatment through enhancement of mRNA stability. FEBS Lett. 579, 4402–4406 [DOI] [PubMed] [Google Scholar]
- 25. Aggeli I. K., Gaitanaki C., Beis I. (2006) Involvement of JNKs and p38-MAPK/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells. Cell. Signal. 18, 1801–1812 [DOI] [PubMed] [Google Scholar]
- 26. Bragado P., Armesilla A., Silva A., Porras A. (2007) Apoptosis by cisplatin requires p53-mediated p38α MAPK activation through ROS generation. Apoptosis 12, 1733–1742 [DOI] [PubMed] [Google Scholar]
- 27. Cai W., Rudolph J. L., Harrison S. M., Jin L., Frantz A. L., Harrison D. A., Andres D. A. (2011) An evolutionarily conserved Rit GTPase-p38 MAPK signaling pathway mediates oxidative stress resistance. Mol. Biol. Cell 22, 3231–3241 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Schewe D. M., Aguirre-Ghiso J. A. (2008) ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 105, 10519–10524 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Frippiat C., Dewelle J., Remacle J., Toussaint O. (2002) Signal transduction in H2O2-induced senescence-like phenotype in human diploid fibroblasts. Free Radic. Biol. Med. 33, 1334–1346 [DOI] [PubMed] [Google Scholar]
- 30. Cao C., Lu S., Kivlin R., Wallin B., Card E., Bagdasarian A., Tamakloe T., Chu W. M., Guan K. L., Wan Y. (2008) AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J. Biol. Chem. 283, 28897–28908 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 31. Xu Q., Konta T., Nakayama K., Furusu A., Moreno-Manzano V., Lucio-Cazana J., Ishikawa Y., Fine L. G., Yao J., Kitamura M. (2004) Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway. Free Radic. Biol. Med. 36, 985–993 [DOI] [PubMed] [Google Scholar]
- 32. Chen L., Xu B., Liu L., Luo Y., Yin J., Zhou H., Chen W., Shen T., Han X., Huang S. (2010) Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cells. Lab. Invest. 90, 762–773 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Jin H. O., Seo S. K., Woo S. H., Kim E. S., Lee H. C., Yoo D. H., An S., Choe T. B., Lee S. J., Hong S. I., Rhee C. H., Kim J. I., Park I. C. (2009) Activating transcription factor 4 and CCAAT/enhancer-binding protein-β negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress. Free Radic. Biol. Med. 46, 1158–1167 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.









